Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated (Q38289586)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated |
scientific article |
Statements
1 reference
Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated (English)
1 reference
Dana Schiefelbein
1 reference
Oliver Seitz
1 reference
Itamar Goren
1 reference
Jan Philipp Dissmann
1 reference
Helmut Schmidt
1 reference
Malte Bachmann
1 reference
Robert Sader
1 reference
Gerd Geisslinger
1 reference
Josef Pfeilschifter
1 reference
Stefan Frank
1 reference
3 July 2008
1 reference
1 reference
74
1 reference
4
1 reference
952-963
1 reference
1 reference
Identifiers
1 reference
1 reference